Translate
Cannabics Pharmaceuticals Inc
About
Cannabics Pharmaceuticals Inc (PINK:CNBX) — investor relations, events, news, and company updates on 6ix.
Latest News
Nov 8 2022
CNBX to Enter the Cancer Immunotherapy Market After Acquiring a Controlling Interest in TaGeza Biopharma
Oct 18 2022
CNBX Files New PCT Patent Application For Cannabinoids-Based Neoadjuvant Cancer Therapy
Oct 13 2022
CNBX Patent Application "Composition and Method for Treating Cancer with Cannabinoids" Enters National Phase in US and Israel
Sep 29 2022
CNBX Peer-reviewed Study: "Possible Future Therapeutic Value" for CNBX Proprietary Drug Candidate
Sep 28 2022
CNBX Pharmaceuticals Announces New Patent Granted in Australia
Financials
Revenue
$0
Market Cap
$87.08 K
P/E Ratio
0.00
EPS
0.00